Prophylactic fluconazole promotes reepithelialization in full-face carbon dioxide laser skin resurfacing

Lasers in Surgery and Medicine

Volumn 26, Issue 2, 2000, Pages 201-207

  Conn, Howard ^a,b   Nanda, Vandana S ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antifungal; CO2 laser; Prophylaxis; Wound healing

Indexed keywords

ACICLOVIR; CEFALEXIN; CIPROFLOXACIN; FLUCONAZOLE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CARBON DIOXIDE LASER; EPITHELIZATION; HUMAN; INFECTION PREVENTION; LASER SURGERY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SKIN SURGERY;

ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; FEMALE; FLUCONAZOLE; HUMANS; MIDDLE AGED; POSTOPERATIVE CARE; RHYTIDOPLASTY; SKIN AGING; SURGICAL WOUND INFECTION; TIME FACTORS; TREATMENT OUTCOME; WOUND HEALING;

EID: 0033999229     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9101(2000)26:2<201::AID-LSM11>3.0.CO;2-0     Document Type: Article

References (17)

1. Fitzpatrick RE. Laser resurfacing of rhytides. Dermatol Clin 1997;15:431-447.
2. Bernstein LJ, Kanvar AB, Grossman MC, Geronemus RG. The short- and long-term side effects of carbon dioxide laser resurfacing. Dermatol Surg 1997;23:519-525.
3. Nanni CA, Alster TS. Complications of carbon dioxide laser resurfacing. An evaluation of 500 patients. Dermatol Surg 1998;24:315-320.
4. Nanni CA, Alster TS. Complications of cutaneous laser surgery. A review. Dermatol Surg 1998;24:209-219.
5. Sriprachya-Anunt S, Fitzpatrick RE, Goldman MP, Smith SR. Infections complicating pulsed carbon dioxide laser resurfacing for photoaged facial skin. Dermatol Surg 1997;23:527-533.
6. Manuskiatti W, Fitzpatrick RE, Goldman MP, Krejci-Papa N. Prophylactic antibiotics in patients undergoing laser resurfacing of the skin. J Am Acad Dermatol 1999; 40:77-84.
7. Fulton JE. Complications of laser resurfacing - methods of prevention and management. Dermatol Surg 1997;24: 209-219.
8. Duke D, Grevelink JM. Care before and after laser skin resurfacing. Dermatol Surg 1998;24:201-206.
9. Zervos EE, Bass SS, Robson MC, Rosemurgy AS. Fluconazole increases bactericidal activity of neutrophils through non-cytokine-mediated pathway. J Trauma Injury Infect Crit Care 1996;41:465-470.
10. Zervos EE, Bass SS, Robson MC, Rosemurgy AS. Fluconazole increases bactericidal activity of neutrophils. J Trauma Injury Infect Crit Care 1996;41:10-14.
11. Goa KL, Barradell LB. Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients. Drugs 1995;50: 658-690.
12. Brummer E, Stevens DA. Synergy of human neutrophils with fluconazole in killing Candida species. Mycopathologia 1996;134:115-120.
13. Natarajan U, Randhawa N, Brummer E, Stevens DA. Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole. J Med Microbiol 1998;47:359-363.
14. DiFrancesco P, Gaziano R, Casalinuovo IA, Palamara AT, Favalli C, Garaci E. Antifungal and immunoadjuvant properties of fluconazole in mice immunosuppressed with morphine. Chemotherapy 1997;43:198-203.
15. Bedford TA, Rowbotham DJ. Cisapride. Drug interactions of clinical significance. Drug Safe 1996;15:167-175.
16. Gray VS. Syncopal episodes associated with cisapride and concurrent drugs. Ann Pharmacother 1998;32:648-651.
17. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicr Agents Chemother 1995; 39:1-8.